Diabetes Drug news from FierceHealthcare
NewsMore objections to Avandia suppressed by Glaxo
We haven't heard anything for a while about Avandia, GlaxoSmithKline's diabetes drug that has been linked to a higher risk of heart attacks, but that doesn't mean no one has been paying attention. Read more...
| Press ReleasesCIGNA and Merck Help Customers Better Manage DiabetesModel Program Improves Health Outcomes and Reduces Overall CostsBlood sugar levels improved by more than 5 percentIndividuals who participated actively in CIGNA’s diabetes support program were more Read more >> |
